Izinova

Magnesium sulfate, sodium sulfate and potassium sulfate, the active ingredients in Izinova, are a mineral salt combination presented as an oral formulation for oral use. It provides electrolyte supplementation and a mild laxative effect in adults. GNH USA supplies Izinova as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Izinova, a combination of mineral salts, is used to address electrolyte balance and bowel function.

- Constipation: provides osmotic laxative action to facilitate bowel movements. - Hypomagnesemia: supplies magnesium to help correct deficiency. - Electrolyte imbalance: delivers sodium and potassium to assist restoration of normal electrolyte levels.

Izinova may cause a range of adverse reactions, most of which are mild and related to its osmotic activity.

Common Side Effects: - Abdominal cramping - Diarrhea - Nausea - Flatulence - Mild electrolyte disturbances (e.g., transient low sodium)

Serious or Rare Side Effects: - Severe dehydration - Hypermagnesemia - Hyperkalemia - Significant electrolyte imbalance - Allergic reaction or anaphylaxis - Acute renal impairment in susceptible individuals

Before using Izinova, consider the following safety measures. - Assess renal function: impaired clearance may increase risk of electrolyte accumulation. - Monitor serum electrolytes: especially magnesium, potassium and sodium levels during therapy. - Use with caution in heart‑failure patients: fluid shifts may affect cardiac status. - Avoid in complete bowel obstruction: risk of perforation or worsening obstruction. - Pregnancy: consult a healthcare provider before use. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Izinova can interact with other medicines that affect electrolyte balance or gastrointestinal motility.

Major Interactions (Avoid): - Potassium‑sparing diuretics: may cause dangerous hyperkalemia. - Calcium channel blockers: enhanced magnesium effects can lead to hypotension. - Other osmotic laxatives: risk of severe electrolyte loss.

Moderate Interactions (Monitor Closely): - Digoxin: altered potassium levels may affect drug activity. - ACE inhibitors: monitor potassium to avoid excess. - Antacids containing magnesium or aluminum: may affect absorption of the salts.